Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis
Read Article
News
2024
2023
Archive
Search news articles
September 25, 2014
EPIRUS AND LIVZON MABPHARM, INC. ENTER COLLABORATION AGREEMENT FOR CHINA
September 23, 2014
EPIRUS ANNOUNCES POSITIVE 58 WEEK FOLLOW UP DATA FOR BOW015 FOR TREATMENT OF RHEUMATOID ARTHRITIS
September 17, 2014
ACHAOGEN ANNOUNCES FIRST PATIENT ENROLLMENT IN A PHASE 3 CLINICAL TRIAL OF PLAZOMICIN TO TREAT INFECTIONS CAUSED BY CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE)
September 9, 2014
FLEXION THERAPEUTICS ANNOUNCES ISSUANCE OF U.S. COMPOSITION OF MATTER PATENT FOR LEAD CANDIDATE FX006
September 4, 2014
NOVIRA THERAPEUTICS ANNOUNCES SUCCESSFUL COMPLETION OF PHASE 1A CLINICAL STUDY ON NVR-1221 AND COMMENCEMENT OF PHASE 1B CLINICAL STUDIES
September 3, 2014
FLEXION THERAPEUTICS TO START FX006 PHASE 3 PIVOTAL TRIAL IN 2014; FOLLOWING FDA MEETING, DEVELOPMENT PLAN ADVANCED BY ONE YEAR
August 7, 2014
FLEXION THERAPEUTICS REPORTS SECOND-QUARTER 2014 FINANCIAL RESULTS
July 28, 2014
VBI AND PAULSON CAPITAL ANNOUNCE COMPLETION OF MERGER
July 1, 2014
BELLEROPHON THERAPEUTICS NAMES JONATHAN PEACOCK CHAIRMAN AND CHIEF EXECUTIVE OFFICER
June 19, 2014
RELYPSA ADDS INDUSTRY VETERANS DANIEL K. SPIEGELMAN AND KENNETH J. HILLAN TO ITS BOARD OF DIRECTORS
« Previous Page
1
…
100
101
102
103
104
…
119
Next Page »